Want to join the conversation?
In Consumer Banking segment, $COF expects persistently low interest rates will continue to pressure returns in deposit businesses, even if rates begin to rise in 2016. $COF expects this pressure along with other headwinds to have a negative impact on revenue and the efficiency ratio for the remainder of 2015 and in 2016.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.